Professor Alan Brennan

All publications

Journal articles

• Bates S, Saidi Y, Cookson R, Skarda I, Ford T, Hayes R, Ganguli P, Byford S & Brennan A (2024) Estimated lifetime impact of a school-based intervention for mental health: A microsimulation study. European Journal of Public Health, 34(Supplement_3).
• Squires H, Kelly MP, Gilbert N, Sniehotta F, Purshouse RC, Garcia L, Breeze P, Brennan A, Gardner B, Bright S , Fischer A et al (2024) The PHEM-B toolbox of methods for incorporating the influences on behaviour into public health economic models. BMC Public Health, 24(1). View this article in WRRO
• Morris D, Angus C, Gillespie D, Stevely A, Pryce R, Wilson L, Henney M, Meier P, Holmes J & Brennan A (2024) Estimating the effect of transitioning to a strength-based alcohol tax system on alcohol consumption and health outcomes: a modelling study of tax reform in England. The Lancet Public Health. View this article in WRRO
• Flight L, Brennan A, Wilson I & Chick SE (2024) A tutorial on value-based adaptive designs: Could a value-based sequential two-arm design have created more health economic value for the Big CACTUS trial?. Value in Health.
• Bates S, Saidi Y, Cookson R, Skarda I, Ford T, Hayes R, Ganguli P, Byford S & Brennan A (2024) Estimating the lifetime costs and benefits of the Incredible Years Teacher Classroom Management intervention using data from 30 months follow up of the STARS Trial. Value in Health.
• Buckell J, Mitchell CA, Fryer K, Newbert C, Brennan A, Joyce J, Jebb SA, Aveyard P, Guess N & Morris E (2024) Erratum. Identifying Preferred Features of Weight Loss Programs for Adults With or at Risk of Type 2 Diabetes: A Discrete Choice Experiment With 3,960 Adults in the U.K. Diabetes Care 2024;47:739–746. Diabetes Care, 47(7), 1239-1239.
• Bates S, Breeze P, Thomas C, Jackson C, Church O & Brennan A (2024) Cross-model validation of public health microsimulation models; comparing two models on estimated effects of a weight management intervention. BMC Public Health, 24. View this article in WRRO
• Höhn A, Lomax N, Rice H, Angus C, Brennan A, Brown D, Cunningham A, Elsenbroich C, Hughes C, Katikireddi SV , McCartney G et al (2024) Estimating quality-adjusted life expectancy (QALE) for local authorities in Great Britain and its association with indicators of the inclusive economy: a cross-sectional study. BMJ Open, 14(3), e076704-e076704.
• Purshouse RC, Buckley C & Brennan A (2024) Commentary on Antosz et al. (2023): The role of macro-micro-macro frameworks and critical realism in agent-based modelling. Environmental Modelling & Software, 173, 105959-105959.
• Mensah J, Thomas C, Akparibo R & Brennan A (2023) SA18 Public Health Economic Modelling in Evaluations of Salt and Alcohol Policies: A Scoping Review. Value in Health, 26(12), S544-S544.
• Pryce R, Wilson LB, Gillespie D, Angus C, Morris D & Brennan A (2023) Estimation of integrated price elasticities for alcohol and tobacco in the United Kingdom using the living costs and food survey 2006–2017. Drug and Alcohol Review.
• Hatchard J, Buykx P, Wilson L, Brennan A & Gillespie D (2023) Mapping alcohol and tobacco tax policy interventions to inform health and economic impact analyses: A United Kingdom based qualitative framework analysis. International Journal of Drug Policy, 122, 104247-104247.
• Pidd K, Breeze P, Pollard D, Ahern A, Mueller J & Brennan A (2023) Estimation of HbA1c after weight loss using a beta-regression for an economic evaluation of a behavioural weight management programme from the GLoW trial: a methodological study. The Lancet, 402, S75-S75.
• Buckley C, Breeze P, Brennan A, Colasanti R, Leach M & Purshouse R (2023) Exploring the relationship between food advertising and consumption of foods high in fat, salt, and sugar in England: an agent-based modelling study. Appetite, 189, 106933-106933.
• Mueller J, Jones RA, Richards R, Woolston J, Whittle F, Hill AJ, Hughes CA, Duschinsky R, Sharp SJ, Boothby C , Bostock J et al (2023) Feasibility and acceptability of an acceptance-based guided self-help programme for weight loss maintenance. Appetite, 189, 106907-106907.
• Stevely AK, Mackay D, Alava MH, Brennan A, Meier PS, Sasso A & Holmes J (2023) Evaluating the effects of minimum unit pricing in Scotland on the prevalence of harmful drinking: a controlled interrupted time series analysis. Public Health, 220, 43-49.
• Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O’Flaherty M , Gilbert N et al (2023) Guidance on the use of complex systems models for economic evaluations of public health interventions. Health Economics.
• Vu TM, Buckley C, Duro JA, Brennan A, Epstein JM & Purshouse RC (2023) Can social norms explain long-term trends in alcohol use? Insights from inverse generative social science. Journal of Artificial Societies and Social Simulation, 26(2).
• Brennan A, Angus C, Pryce R, Buykx P, Henney M, Gillespie D, Holmes J & Meier PS (2022) Effectiveness of subnational implementation of minimum unit price for alcohol: policy appraisal modelling for local authorities in England. Addiction.
• Ahern AL, Breeze P, Fusco F, Sharp SJ, Islam N, Wheeler GM, Hill AJ, Hughes CA, Duschinsky R, Thomas C , Bates S et al (2022) Effectiveness and cost-effectiveness of referral to a commercial open group behavioural weight management programme in adults with overweight and obesity: 5-year follow-up of the WRAP randomised controlled trial. The Lancet Public Health, 7(10), e866-e875.
• Broadley M, Chatwin H, Søholm U, Amiel SA, Carlton J, De Galan BE, Hendrieckx C, McCrimmon RJ, Skovlund SE, Pouwer F & Speight J (2022) The 12-Item Hypoglycemia Impact Profile (HIP12): psychometric validation of a brief measure of the impact of hypoglycemia on quality of life among adults with type 1 or type 2 diabetes. BMJ Open Diabetes Research and Care, 10(4).
• Thomas C, Breeze P, Cummins S, Cornelsen L, Yau A & Brennan A (2022) The health, cost and equity impacts of restrictions on the advertisement of high fat, salt and sugar products across the transport for London network: a health economic modelling study. International Journal of Behavioral Nutrition and Physical Activity, 19. View this article in WRRO
• Divilly P, Zaremba N, Mahmoudi Z, Søholm U, Pollard D, Broadley M, Abbink E, de Galan B, Pedersen-Bjergaard U, Renard E , Evans M et al (2022) Hypo-METRICS: Hypoglycaemia – MEasurement, ThResholds and ImpaCtS – A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: the study protocol. Diabetic Medicine. View this article in WRRO
• Ahern AL, Richards R, Jones RA, Whittle F, Mueller J, Woolston J, Sharp SJ, Hughes CA, Hill AJ, Duschinsky R , Lawlor ER et al (2022) Acceptability and feasibility of an acceptance and commitment therapy-based guided self-help intervention for weight loss maintenance in adults who have previously completed a behavioural weight loss programme: the SWiM feasibility study protocol.. BMJ Open, 12(4), e058103.
• Kersbergen I, Buykx P, Brennan A, Brown J, Michie S & Holmes J (2022) Print and online textual news media coverage of UK low-risk drinking guidelines from 2014 to 2017 : a review and thematic analysis. Drug and Alcohol Review. View this article in WRRO
• Bates SE, Thomas C, Islam N, Ahern AL, Breeze P, Griffin S & Brennan A (2022) Using health economic modelling to inform the design and development of an intervention : estimating the justifiable cost of weight loss maintenance in the UK. BMC Public Health, 22(1). View this article in WRRO
• Søholm U, Broadley M, Zaremba N, Divilly P, Nefs G, Mahmoudi Z, de Galan B, Pedersen-Bjergaard U, Brennan A, Pollard DJ , McCrimmon RJ et al (2022) Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application. BMJ Open, 12(2). View this article in WRRO
• Richards R, Jones RA, Whittle F, Hughes CA, Hill AJ, Lawlor ER, Bostock J, Bates S, Breeze PR, Brennan A , Thomas CV et al (2022) Development of a Web-Based, Guided Self-help, Acceptance and Commitment Therapy-Based Intervention for Weight Loss Maintenance: Evidence-, Theory-, and Person-Based Approach.. JMIR Form Res, 6(1), e31801.
• Flight L, Julious S, Brennan A & Todd S (2021) Expected value of sample information to guide the design of group sequential clinical trials. Medical Decision Making. View this article in WRRO
• Khunti K, Griffin S, Brennan A, Dallosso H, Davies M, Eborall H, Edwardson C, Gray L, Hardeman W, Heathcote L , Henson J et al (2021) Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.. Health Technology Assessment, 25(77).
• Buckley C, Field M, Vu TM, Brennan A, Greenfield TK, Meier PS, Nielsen A, Probst C, Shuper PA & Purshouse RC (2021) An integrated dual process simulation model of alcohol use behaviours in individuals, with application to US population-level consumption, 1984-2012. Addictive Behaviors, 107094-107094.
• Matteo Luca Battisti N, Hatton MQ, WR Reed M, Herbert E, Morgan JL, Bradburn M, Simcock R, Walters SJ, Collins KA, Ward SE , Holmes GR et al (2021) Observational cohort study in older women with early breast cancer: use of radiation therapy and impact on health-related quality of life and mortality. Radiotherapy and Oncology.
• Khunti K, Griffin S, Brennan A, Dallosso H, Davies MJ, Eborall HC, Edwardson CL, Gray LJ, Hardeman W, Heathcote L , Henson J et al (2021) Promoting physical activity in a multi-ethnic population at high risk of diabetes: the 48-month PROPELS randomised controlled trial. BMC Medicine, 19. View this article in WRRO
• Ring A, Battisti NML, Reed MWR, Herbert E, Morgan JL, Bradburn M, Walters SJ, Collins KA, Ward SE, Holmes GR , Burton M et al (2021) Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer.. British Journal of Cancer. View this article in WRRO
• Rehm J, Patra J, Brennan A, Buckley C, Greenfield TK, Kerr WC, Manthey J, Purshouse RC, Rovira P, Shuper PA & Shield KD (2021) The role of alcohol use in the aetiology and progression of liver disease: a narrative review and a quantification. Drug and Alcohol Review.
• Morgan JL, Shrestha A, Reed MWR, Herbert E, Bradburn M, Walters SJ, Martin C, Collins K, Ward S, Holmes G , Burton M et al (2021) Bridging the age gap in breast cancer : impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes. British Journal of Surgery, 108(3), 315-325. View this article in WRRO
• Patra J, Buckley C, Kerr WC, Brennan A, Purshouse RC & Rehm J (2021) Impact of body mass and alcohol consumption on all‐cause and liver mortality in 240 000 adults in the United States. Drug and Alcohol Review.
• Brennan A, Angus C, Pryce R, Buykx P, Henney M, Gillespie D, Holmes J & Meier PS (2021) Potential effects of minimum unit pricing at local authority level on alcohol-attributed harms in North West and North East England: a modelling study. Public Health Research, 9(4).
• Battisti NML, Reed MWR, Herbert E, Morgan JL, Collins KA, Ward SE, Holmes GR, Bradburn M, Walters SJ, Burton M , Lifford K et al (2021) Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer. European Journal of Cancer, 144, 269-280.
• Holmes GR, Ward SE, Brennan A, Bradburn M, Morgan JL, Reed MWR, Richards P, Rafia R, Wyld L, Burton M , Lifford K et al (2021) Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer. Value in Health.
• Wyld L, Reed MWR, Morgan J, Collins K, Ward S, Holmes GR, Bradburn M, Walters S, Burton M, Herbert E , Lifford K et al (2021) Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life. European Journal of Cancer, 142, 48-62.
• Schneider PP, Smith RA, Bullas AM, Quirk H, Bayley T, Haake SJ, Brennan A & Goyder E (2020) Multiple deprivation and geographic distance to community physical activity events — achieving equitable access to parkrun in England. Public Health, 189, 48-53. View this article in WRRO
• Holmes J, Beard E, Brown J, Brennan A, Kersbergen I, Meier PS, Michie S, Stevely AK & Buykx P (2020) The impact of promoting revised UK low-risk drinking guidelines on alcohol consumption: interrupted time series analysis. Public Health Research, 8(14). View this article in WRRO
• Si L, Willis MS, Asseburg C, Nilsson A, Tew M, Clarke PM, Lamotte M, Ramos M, Shao H, Shi L , Zhang P et al (2020) Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials : a report on the Ninth Mount Hood Diabetes Challenge. Value in Health. View this article in WRRO
• Moore S, Allen D, Amos Y, Blake J, Brennan A, Buykx P, Goodacre S, Gray L, Irving A, O'Cathain A , Sivarajasingam V et al (2020) Evaluating alcohol intoxication management services: the EDARA mixed-methods study. Health Services and Delivery Research, 8(24). View this article in WRRO
• Vu TM, Buckley C, Bai H, Nielson A, Probst C, Brennan A, Shuper P, Strong M & Purshouse R (2020) Multiobjective genetic programming can improve the explanatory capabilities of mechanism-based models of social systems. Complexity, 2020. View this article in WRRO
• Thokala P, Dodd P, Baalbaki H, Brennan A, Dixon S & Lowrie K (2020) Developing Markov models from real-world data: A case study of heart failure modeling using administrative data. Value in Health, 23(6), 743-750. View this article in WRRO
• Winkley K, Upsher R, Stahl D, Pollard D, Kasera A, Brennan A, Heller S & Ismail K (2020) Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review. Health Technology Assessment, 24(28). View this article in WRRO
• Vu T, Probst C, Nielsen A, Bai H, Buckley C, Meier P, Strong M, Brennan A & Purshouse R (2020) A software architecture for mechanism-based social systems modelling in agent-based simulation models. Journal of Artificial Societies and Social Simulation, 23(3). View this article in WRRO
• Kunst N, Wilson ECF, Glynn D, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2020) Computing the expected value of sample information efficiently: practical guidance and recommendations for four model-based methods. Value in Health. View this article in WRRO
• Ahern AL, Woolston J, Wells E, Sharp SJ, Islam N, Lawlor ER, Duschinsky R, Hill AJ, Doble B, Wilson E , Morris S et al (2020) Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes : study protocol for the glucose lowering through weight management (GLoW) randomised controlled trial. BMJ Open, 10(4). View this article in WRRO
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller SR & Ismail K (2020) Psychological interventions to improve glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Research & Care, 8(1). View this article in WRRO
• Angus C, Pryce R, Holmes J, de Vocht F, Hickman M, Meier P, Brennan A & Gillespie D (2020) Assessing the contribution of alcohol-specific causes to socio-economic inequalities in mortality in England and Wales 2001-16. Addiction. View this article in WRRO
• Flight L, Julious S, Brennan A, Todd S & Hind D (2020) How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis. Trials, 21(1). View this article in WRRO
• Churchill S, Angus C, Purshouse R, Brennan A & Sherk A (2020) Expanding attributable fraction applications to outcomes wholly attributable to a risk factor. Statistical Methods in Medical Research. View this article in WRRO
• Langley T, Gillespie D, Lewis S, Eminson K, Brennan A, Docherty G & Young B (2020) Developing logic models to inform public health policy outcome evaluation : an example from tobacco control. Journal of Public Health. View this article in WRRO
• Probst C, Vu TM, Epstein JM, Nielsen AE, Buckley C, Brennan A, Rehm J & Purshouse RC (2020) The normative underpinnings of population-level alcohol use: An individual-level simulation model. Health Education and Behavior. View this article in WRRO
• Vocht F, McQuire C, Brennan A, Egan M, Angus C, Kaner E, Beard E, Brown J, De Angelis D, Carter N , Murray B et al (2020) Evaluating the causal impact of individual alcohol licensing decisions on local health and crime using natural experiments with synthetic controls. Addiction. View this article in WRRO
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K (2020) Systematic review and meta‐analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes. Diabetic Medicine. View this article in WRRO
• Jiang H, Livingston M, Room R, Callinan S, Marzan M, Brennan A & Doran C (2020) Modelling the effects of alcohol pricing policies on alcohol consumption in subpopulations in Australia. Addiction. View this article in WRRO
• Pryce R, Angus C, Holmes J, Gillespie D, Buykx P, Meier P, Hickman M, de Vocht F & Brennan A (2020) Reweighting national survey data for small area behaviour estimates : modelling alcohol consumption in local authorities in England. Population Health Metrics, 18(1). View this article in WRRO
• Kearns B, Stevens J, Ren S & Brennan A (2020) How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness. PharmacoEconomics, 38(2), 193-204. View this article in WRRO
• Bates S, Bayley T, Norman P, Breeze P & Brennan A (2019) A systematic review of methods to predict weight trajectories in health economic models of behavioral weight management programs : the potential role of psychosocial factors. Medical Decision Making. View this article in WRRO
• Meier P, Purshouse R, Bain M, Bambra C, Bentall R, Birkin M, Brazier J, Brennan A, Bryan M, Cox J , Fell G et al (2019) The SIPHER consortium : introducing the new UK hub for systems science in public health and health economic research. Wellcome Open Research, 4. View this article in WRRO
• Eminson K, Gillespie D, Lewis S, Opazo-Breton M, Bogdanovica I, Brennan A, Britton J, Wu Q, Meier P, Holmes J & Langley T (2019) OP87 A comprehensive evaluation of the impact of recent english tobacco control policy using secondary data. Oral Presentations.
• Marchand R, Genovese A, Koh SCL & Brennan A (2019) Examining the relationship between energy poverty and measures of deprivation. Energy Policy, 130, 206-217. View this article in WRRO
• Jiang H, Room R, Livingston M, Callinan S, Brennan A, Doran C & Thorn M (2019) The effects of alcohol pricing policies on consumption, health, social and economic outcomes, and health inequality in Australia : a protocol of an epidemiological modelling study. BMJ Open, 9(6). View this article in WRRO
• Holmes J, Angus C, Meier PS, Buykx P & Brennan A (2019) Drinking guidelines and the need for evidence beyond the epidemiological. Addiction, 114(4), 607-608.
• Flight L, Arshad F, Barnsley R, Patel K, Julious S, Brennan A & Todd S (2019) A Review of Clinical Trials with an Adaptive Design and Health Economic Analysis. Value in Health. View this article in WRRO
• Brennan A, Hill-McManus D, Stone T, Buykx P, Ally A, Pryce RE, Alston R, Jones A, Cairns D, Millar T , Donmall M et al (2019) Modeling the Potential Impact of Changing Access Rates to Specialist Treatment for Alcohol Dependence for Local Authorities in England: The Specialist Treatment for Alcohol Model (STreAM).. Journal of Studies on Alcohol and Drugs Supplement(Sup 18), 96-109. View this article in WRRO
• Di Tanna GL, Porter JK, Lipton RB, Brennan A, Palmer S, Hatswell AJ, Sapra S & Villa G (2019) Migraine day frequency in migraine prevention: longitudinal modelling approaches. BMC Medical Research Methodology, 19. View this article in WRRO
• Angus C, Li J, Romero-Rodriguez E, Anderson P, Parrott S & Brennan A (2019) Cost-effectiveness of strategies to improve delivery of brief interventions for heavy drinking in primary care: results from the ODHIN trial. European Journal of Public Health, 29(2), 219-225. View this article in WRRO
• Bhattacharya A, Angus C, Pryce R, Holmes J, Brennan A & Meier PS (2018) How dependent is the alcohol industry on heavy drinking in England?. Addiction, 113(12), 2225-2232. View this article in WRRO
• Addison M, Mcgovern R, Angus C, Becker F, Brennan A, Brown H, Coulton S, Crowe L, Gilvarry E, Hickman M , Howel D et al (2018) Alcohol Screening and Brief Intervention in Police Custody Suites: Pilot Cluster Randomised Controlled Trial (AcCePT). Alcohol and Alcoholism, 53(5), 548-559. View this article in WRRO
• Holmes J, Angus C, Meier PS, Buykx P & Brennan A (2018) How should we set consumption thresholds for low risk drinking guidelines? Achieving objectivity and transparency using evidence, expert judgement and pragmatism. Addiction. View this article in WRRO
• Lipton RB, Brennan A, Palmer S, Hatswell AJ, Porter JK, Sapra S, Villa G, Shah N, Tepper S & Dodick D (2018) Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. Journal of Medical Economics, 21(7), 666-675. View this article in WRRO
• de Vocht F, Angus C, Tilling K, Brennan A & Hickman M (2018) Response to: ‘Synthetic control methodology as a tool for evaluating population-level health interventions’ by Bouttell et al. Journal of Epidemiology and Community Health, 72(9), 864-864.
• Breeze P, Womack R, Pryce R, Brennan A & Goyder E (2018) The impact of a local sugar sweetened beverage health promotion and price increase on sales in public leisure centre facilities. PLoS ONE, 13(5). View this article in WRRO
• Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, McEwan P, Leal J, Gray A, Foos V , Lamotte M et al (2018) Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge. Value in Health. View this article in WRRO
• Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H & White D (2018) Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. BMJ Open, 8(4). View this article in WRRO
• Penn L, Rodrigues A, Haste A, Marques MM, Budig K, Sainsbury K, Bell R, Araújo-Soares V, White M, Summerbell C , Goyder E et al (2018) NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation. BMJ Open, 8(2), e019467-e019467. View this article in WRRO
• Holmes J, Meier PS, Angus C & Brennan A (2018) Scotland's policy on minimum unit pricing for alcohol: the legal barriers are gone, so what are the implications for implementation and evaluation?. Addiction, 113(2), 203-204.
• Purshouse RC, Brennan A, Holmes J & Meier PS (2018) Commentary on Apostolopoulos et al . (2018): Systems and complex systems approaches for public health planning-back to the future?. Addiction, 113(2), 372-373.
• Grimm SE, Strong M, Brennan A & Wailoo A (2017) The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment. PharmacoEconomics, 35(12), 1287-1296. View this article in WRRO
• Meier P, Brennan A, Angus C & Holmes J (2017) Minimum unit pricing for alcohol clears final legal hurdle in Scotland.. BMJ, 359. View this article in WRRO
• Salleh S, Thokala P, Brennan A, Hughes R & Dixon S (2017) Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment. PharmacoEconomics, 35(10), 989-1006. View this article in WRRO
• de Vocht F, Tilling K, Pliakas T, Angus C, Egan M, Brennan A, Campbell R & Hickman M (2017) The intervention effect of local alcohol licensing policies on hospital admission and crime: a natural experiment using a novel Bayesian synthetic time-series method. Journal of Epidemiology and Community Health, 71, 912-918. View this article in WRRO
• Salleh S, Thokala P, Brennan A, Hughes R & Booth A (2017) Simulation Modelling in Healthcare: An Umbrella Review of Systematic Literature Reviews. PharmacoEconomics, 35(9), 937-949. View this article in WRRO
• Thomas C, Sadler S, Breeze P, Squires H, Gillett M & Brennan A (2017) Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. BMJ Open, 7. View this article in WRRO
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, Brunner E, Tabak A, Preston L & Chilcott J (2017) Cost‐effectiveness of population‐based, community, workplace and individual policies for diabetes prevention in the UK. Diabetic Medicine, 34(8), 1136-1144. View this article in WRRO
• Gavens L, Holmes J, Buykx P, de Vocht F, Egan M, Grace D, Lock K, Mooney JD & Brennan A (2017) Processes of local alcohol policy-making in England: Does the theory of policy transfer provide useful insights into public health decision-making?. Health & Place. View this article in WRRO
• Purshouse RC, Brennan A, Moyo D, Nicholls J & Norman P (2017) Typology and Dynamics of Heavier Drinking Styles in Great Britain: 1978–2010. Alcohol and Alcoholism, 52(3), 372-381. View this article in WRRO
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle PJ, Brunner E, Tabak A, Preston L & Chilcott J (2017) The impact of Type 2 diabetes prevention programmes based on risk‐identification and lifestyle intervention intensity strategies: a cost‐effectiveness analysis. Diabetic Medicine, 34(5), 632-640. View this article in WRRO
• Angus CR, Holmes J, Maheswaran R, Green M, Meier P & Brennan A (2017) Mapping Patterns and Trends in the Spatial Availability of Alcohol Using Low-Level Geographic Data: A Case Study in England 2003–2013. International Journal of Environmental Research and Public Health, 4. View this article in WRRO
• Sadler S, Angus C, Gavens L, Gillespie D, Holmes J, Hamilton J, Brennan A & Meier P (2017) Understanding the alcohol harm paradox: an analysis of sex- and condition-specific hospital admissions by socioeconomic group for alcohol-associated conditions in England.. Addiction, 112(5), 808-817. View this article in WRRO
• Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, Amiel S, Barnard K, Beckwith A, Brennan A , Campbell M et al (2017) A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. Health Technology Assessment, 21(20), 1-278. View this article in WRRO
• Angus CR, Thomas C, Anderson P, Meier P & Brennan A (2017) Estimating the cost-effectiveness of brief interventions for heavy drinking in primary health care across Europe. European Journal of Public Health, 27(2), 345-351. View this article in WRRO
• Heller S, Amiel S, Campbell M, Choudhary P, Cooper C, Dimairo M, Elliott J, Hammond P, Lee E, Lindsay R , Waugh N et al (2017) Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ, 356. View this article in WRRO
• Holloway AS, Ferguson J, Landale S, Cariola L, Newbury-Birch D, Flynn A, Knight JR, Sherritt L, Harris SK, O’Donnell AJ , Kaner E et al (2017) Proceedings of the 14th annual conference of INEBRIA. Addiction Science & Clinical Practice, 12(S1). View this article in WRRO
• Breeze P, Squires H, Chilcott J, Stride C, Diggle PJ, Brunner E, Tabak A & Brennan A (2016) A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study.. J Public Health (Oxf), 38(4), 679-687. View this article in WRRO
• Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H & Kruger J (2016) The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes. Medical Decision Making, 36(8), 1020-1033. View this article in WRRO
• Thomas C, Breeze P, Strong M, Brennan A, Norman P, Cameron D & Epton T (2016) The cost-effectiveness of an updated theory-based online health behavior intervention for new university students: U@Uni2. Journal of Public Health & Epidemiology, 8(10), 191-203. View this article in WRRO
• Basarir H, Brennan A, Jacques RM, Pollard D, Stevens K, Freeman J, Wales J & Price K (2016) Cost-effectiveness of structured education in children with type-1 diabetes mellitus. International Journal of Technology Assessment in Health Care, 32(4), 203-211. View this article in WRRO
• Beard E, Brown J, West R, Angus C, Brennan A, Holmes J, Kaner E, Meier P & Michie S (2016) Deconstructing the Alcohol Harm Paradox: A Population Based Survey of Adults in England.. PLoS One, 11(9), e0160666-e0160666. View this article in WRRO
• De Vocht F, Brown J, Beard E, Angus C, Brennan A, Michie S, Campbell R & Hickman M (2016) Temporal patterns of alcohol consumption and attempts to reduce alcohol intake in England. BMC Public Health, 16(1). View this article in WRRO
• Egan M, Brennan A, Buykx PF, De Vocht F, Gavens L, Grace D, Halliday E, Hickman M, Holt V, Mooney J & Lock K (2016) Local policies to tackle a national problem: comparative qualitative case studies of an English local authority alcohol availability intervention.. Health and Place, 41, 11-18. View this article in WRRO
• Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J , Weaver T et al (2016) An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence. Addiction, 111(9), 1616-1627. View this article in WRRO
• Ally A, Lovatt M, Meier PS, Brennan A & Holmes J (2016) Developing a social practice-based typology of British drinking culture in 2009–2011: implications for alcohol policy analysis. Addiction, 111(9), 1568-1579. View this article in WRRO
• De Vocht F, Heron J, Campbell R, Egan M, Mooney JD, Angus C, Brennan A & Hickman M (2016) Testing the impact of local alcohol licencing policies on reported crime rates in England. Journal of Epidemiology and Community Health, jech-2016-207753-jech-2016-207753. View this article in WRRO
• Graham J, McBride D, Stull D, Halliday A, Alexopoulos ST, Balp M-M, Griffiths M, Agirrezabal I, Zuberbier T & Brennan A (2016) Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria. PharmacoEconomics, 34(8), 815-827. View this article in WRRO
• Holmes J, Brown J, West R, Beard E, Brennan A, Drummond C, Gillespie D, Hickman M, Holmes J, Kaner E & Michie S (2016) Are recent attempts to quit smoking associated with reduced drinking in England? A cross-sectional population survey. BMC Public Health, 16:535. View this article in WRRO
• Rafia R, Brennan A, Madan J, Collins K, Reed MWR, Lawrence G, Robinson T, Greenberg D & Wyld L (2016) Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales. Value in Health, 19(4), 404-412.
• de Vocht F, Heron J, Angus C, Brennan A, Mooney J, Lock K, Campbell R & Hickman M (2016) Measurable effects of local alcohol licensing policies on population health in England. Journal of Epidemiology and Community Health, 70(3), 231-237. View this article in WRRO
• Meier PS, Holmes J, Angus C, Ally AK, Meng Y & Brennan A (2016) Estimated Effects of Different Alcohol Taxation and Price Policies on Health Inequalities: A Mathematical Modelling Study. PLOS Medicine, 13(2), e1001963-e1001963. View this article in WRRO
• Brennan A, Meier P, Purshouse R, Rafia R, Meng Y & Hill-Macmanus D (2016) Developing policy analytics for public health strategy and decisions—the Sheffield alcohol policy model framework. Annals of Operations Research, 236(1), 149-176. View this article in WRRO
• Brown J, West R, Angus C, Beard E, Brennan A, Drummond C, Hickman M, Holmes J, Kaner E & Michie S (2016) Comparison of brief interventions in primary care on smoking and excessive alcohol consumption: a population survey in England. British Journal of General Practice, 66(642), e1-e9. View this article in WRRO
• de Vocht F, Campbell R, Brennan A, Mooney J, Angus C & Hickman M (2016) Propensity score matching for selection of local areas as controls for evaluation of effects of alcohol policies in case series and quasi case–control designs. Public Health, 132, 40-49. View this article in WRRO
• (2016) Retracted:Impact of Type 2 diabetes prevention programmes based on risk identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. Diabetic Medicine, 33(8), 1155-1163.
• Price KJ, Knowles JA, Fox M, Wales JKH, Heller S, Eiser C, Freeman JV, Brennan A, Basirir H, Stevens K & McPherson A (2016) Effectiveness of the Kids in Control of Food (KICk-OFF) structured education course for 11-16 year olds with Type 1 diabetes. Diabetic Medicine, 33(2), 192-203.
• Lawton J, Kirkham J, Rankin D, White DA, Elliott J, Jaap A, Smithson WH, Heller S, Gianfrancesco C, Gordon V , Greaves L et al (2016) Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial. Diabetic Medicine, 33(2), 243-251.
• Cameron D, Norman P, Epton T, Sheeran P, Harris PR, Webb TL, Julious SA, Brennan A, Thomas C, Petroczi A , Naughton D et al (2015) A theory-based online health behaviour intervention for new university students (U@Uni:LifeGuide): Results from a repeat randomized controlled trial. Trials, 16. View this article in WRRO
• Breeze P & Brennan A (2015) Valuing Trial Designs from a Pharmaceutical Perspective Using Value-Based Pricing. Health Economics (United Kingdom), 24(11), 1468-1482. View this article in WRRO
• Kruger J, Pollard DJ, Basarir H, Thokala P, Cooke D, Clark M, Bond R, Heller S & Brennan A (2015) Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models: A Case Study in Type 1 Diabetes. Medical Decision Making, 35(7), 872-887. View this article in WRRO
• Brennan A, Meier P, Purshouse R, Rafia R, Meng Y, Hill-Macmanus D, Angus C & Holmes J (2015) The Sheffield Alcohol Policy Model - A Mathematical Description. Health Economics, 24(10), 1368-1388. View this article in WRRO
• Strong M, Oakley JE, Brennan A & Breeze P (2015) Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample. Medical Decision Making, 35(5), 570-583. View this article in WRRO
• Birch J, Scott S, Newbury-Birch D, Brennan A, Brown H, Coulton S, Gilvarry E, Hickman M, McColl E, McGovern R , Muirhead C et al (2015) A pilot feasibility trial of alcohol screening and brief intervention in the police custody setting (ACCEPT): study protocol for a cluster randomised controlled trial. Pilot and Feasibility Studies, 1(1). View this article in WRRO
• Watson P, Brennan A, Birch H, Fang H & Petri M (2015) An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins Lupus Cohort. Rheumatology, 54(4), 623-632.
• Ally AK, Meng Y, Chakraborty R, Dobson PW, Seaton JS, Holmes J, Angus C, Guo Y, Hill-McManus D, Brennan A & Meier PS (2014) Alcohol tax pass-through across the product and price range: do retailers treat cheap alcohol differently?. Addiction, 109(12), 1994-2002. View this article in WRRO
• Mooney JD, Holmes J, Brennan A, Meier PS, Hickman M & Lock K (2014) Investigating local policy drivers for alcohol harm prevention: a comparative case study of two local authorities in England. The Lancet, 384, S52-S52.
• Holmes J, Meier PS, Booth A & Brennan A (2014) Reporting the characteristics of the policy context for population-level alcohol interventions: A proposed ‘Transparent Reporting of Alcohol Intervention ContExts’ (TRAICE) checklist. Drug and Alcohol Review, 33(6), 596-603. View this article in WRRO
• Lawton J, Kirkham J, Rankin D, Barnard K, Cooper CL, Taylor C, Heller S & Elliott J (2014) Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: A longitudinal qualitative investigation. Diabetes Research and Clinical Practice, 106(3), 443-450. View this article in WRRO
• Brennan A, Meng Y, Holmes J, Hill-McManus D & Meier PS (2014) Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling study. BMJ, 349. View this article in WRRO
• Holmes J, Guo Y, Maheswaran R, Nicholls J, Meier PS & Brennan A (2014) The impact of spatial and temporal availability of alcohol on its consumption and related harms: A critical review in the context of UK licensing policies. Drug and Alcohol Review, 33(5), 515-525. View this article in WRRO
• Elliott J, Jacques RM, Kruger J, Campbell MJ, Amiel SA, Mansell P, Speight J, Brennan A & Heller SR (2014) Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes.. Diabet Med, 31(7), 847-853. View this article in WRRO
• Epton T, Norman P, Dadzie A-S, Harris PR, Webb TL, Sheeran P, Julious SA, Ciravegna F, Brennan A, Meier PS , Naughton D et al (2014) A theory-based online health behaviour intervention for new university students (U@Uni): Results from a randomised controlled trial. Acta Veterinaria Scandinavica, 563-563. View this article in WRRO
• Watson P, Preston L, Squires H, Chilcott J & Brennan A (2014) Modelling the economics of type 2 diabetes mellitus prevention: a literature review of methods.. Appl Health Econ Health Policy, 12(3), 239-253.
• Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, Guo Y, Hill-McManus D & Purshouse RC (2014) Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study.. Lancet, 383(9929), 1655-1664. View this article in WRRO
• Strong M, Oakley JE & Brennan A (2014) Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample: A Nonparametric Regression Approach. Medical Decision Making, 34(3), 311-326. View this article in WRRO
• Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, Gillett M, Elliott J & Heller S (2014) Assessing the cost-effectiveness of type 1 diabetes interventions: the Sheffield type 1 diabetes policy model.. Diabet Med, 31(4), 477-486.
• Meng Y, Brennan A, Purshouse R, Hill-McManus D, Angus C, Holmes J & Meier PS (2014) Estimation of own and cross price elasticities of alcohol demand in the UK--A pseudo-panel approach using the Living Costs and Food Survey 2001-2009.. J Health Econ, 34, 96-103. View this article in WRRO
• Angus C, Scafato E, Ghirini S, Torbica A, Ferre F, Struzzo P, Purshouse R & Brennan A (2014) Cost-effectiveness of a programme of screening and brief interventions for alcohol in primary care in Italy.. BMC Fam Pract, 15, 26. View this article in WRRO
• Meng Y, Holmes J, Hill-McManus D, Brennan A & Meier PS (2014) Trend analysis and modelling of gender-specific age, period and birth cohort effects on alcohol abstention and consumption level for drinkers in Great Britain using the General Lifestyle Survey 1984-2009.. Addiction, 109(2), 206-215. View this article in WRRO
• Kruger J, Brennan A, Strong M, Thomas C, Norman P & Epton T (2014) The cost-effectiveness of a theory-based online health behaviour intervention for new university students: an economic evaluation. BMC Public Health, 14(1). View this article in WRRO
• Purshouse RC, Ally AK, Brennan A, Moyo D & Norman P (2014) Evolutionary parameter estimation for a theory of planned behaviour microsimulation of alcohol consumption dynamics in an English birth cohort 2003 to 2010. Proceedings of the 2014 conference on Genetic and evolutionary computation - GECCO '14.
• Hill-McManus D, Angus C, Meng Y, Holmes J, Brennan A & Sylvia Meier P (2014) Estimation of usual occasion-based individual drinking patterns using diary survey data. Drug and Alcohol Dependence, 134(1), 136-143.
• Richards P & Brennan A (2013) Designing clinical research into the treatment of breast cancer in the elderly - the advantages and challenges of a value of information approach. Trials, 14(S1).
• Strong M, Brennan A & Oakley J (2013) Fast efficient computation of expected value of sample information from a probabilistic sensitivity analysis sample: a non-parametric regression approach. Trials, 14(S1).
• Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, Wong R, Brennan A & Fitzgerald P (2013) Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.. Health Technol Assess, 17(32), 1-vi. View this article in WRRO
• Norman P, Epton T, Dadzie A-S, Sheeran P, Harris P, Webb T, Ciravegna F, Julious S, Brennan A, Meier P , Kruger J et al (2013) A theory-based online intervention to promote health behaviour in new university students: One-month follow-up data. PSYCHOLOGY & HEALTH, 28, 132-132.
• Kruger J, Brennan A, Thokala P, Basarir H & Heller S (2013) The cost-effectiveness of Dose Adjustment for Normal Eating (DAFNE) structured education in Type 1 diabetes: an update using the Sheffield Type 1 diabetes policy model. DIABETIC MEDICINE, 30, 133-134.
• Meier PS, Meng Y, Holmes J, Baumberg B, Purshouse R, Hill-McManus D & Brennan A (2013) Adjusting for unrecorded consumption in survey and per capita sales data: quantification of impact on gender- and age-specific alcohol-attributable fractions for oral and pharyngeal cancers in Great Britain.. Alcohol Alcohol, 48(2), 241-249. View this article in WRRO
• Kruger J, Brennan A, Thokala P, Basarir H, Jacques R, Elliott J, Heller S & Speight J (2013) The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model. DIABETIC MEDICINE, 30(10), 1236-1244.
• Purshouse RC, Brennan A, Rafia R, Latimer NR, Archer RJ, Angus CR, Preston LR & Meier PS (2013) Modelling the cost-effectiveness of alcohol screening and brief interventions in primary care in England.. Alcohol Alcohol, 48(2), 180-188.
• Price KJ, Wales J, Eiser C, Knowles J, Heller S, Freeman J, Brennan A, McPherson A & Wellington J (2013) Does an intensive self-management structured education course improve outcomes for children and young people with type 1 diabetes? The Kids In Control OF Food (KICk-OFF) cluster-randomised controlled trial protocol.. BMJ Open, 3(1). View this article in WRRO
• Tosh J, Kearns B, Brennan A, Parry G, Ricketts T, Saxon D, Kilgarriff-Foster A, Thake A, Chambers E & Hutten R (2013) Innovation in Health Economic Modelling of Service Improvements for Longer-Term Depression: Demonstration in a Local Health Community. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 16, S34-S35.
• Thokala P, Baalbaki H, Brennan A, Pandor A, Stevens JW, Gomersall T, Wang J, Bakhai A, Al-Mohammad A, Cleland J , Cowie MR et al (2013) Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs.. BMJ Open, 3(9), e003250. View this article in WRRO
• Tappenden P, Chilcott J, Brennan A, Squires H, Glynne-Jones R & Tappenden J (2013) Using Whole Disease Modeling to Inform Resource Allocation Decisions: Economic Evaluation of a Clinical Guideline for Colorectal Cancer Using a Single Model. Value in Health.
• Tosh J, Kearns B, Brennan A, Parry G, Ricketts T, Saxon D, Kilgarriff-Foster A, Thake A, Chambers E & Hutten R (2013) Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community.. BMC Health Serv Res, 13, 150. View this article in WRRO
• Epton T, Norman P, Sheeran P, Harris PR, Webb TL, Ciravegna F, Brennan A, Meier P, Julious SA, Naughton D , Petroczi A et al (2013) A theory-based online health behavior intervention for new university students: study protocol.. BMC Public Health, 13, 107. View this article in WRRO
• Kruger J & Brennan A (2013) The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies.. Eur J Health Econ, 14(6), 887-899. View this article in WRRO
• Tappenden P, Chilcott J, Brennan A, Squires H & Stevenson M (2012) Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework.. Value Health, 15(8), 1127-1136.
• Karnon J, Stahl J, Brennan A, Caro JJ, Mar J & Möller J (2012) Modeling using discrete event simulation: A report of the ISPOR-SMDM modeling good research practices task force-4. Medical Decision Making, 32(5), 701-711.
• Gillett M, Royle P, Snaith A, Scotland G, Poobalan A, Imamura M, Black C, Boroujerdi M, Jick S, Wyness L , McNamee P et al (2012) Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.. Health Technol Assess, 16(33), 1-iv.
• Karnon J, Stahl J, Brennan A, Caro JJ, Mar J & Möller J (2012) Modeling using discrete event simulation: A report of the ISPOR-SMDM modeling good research practices task force-4. Value in Health, 15(6), 821-827.
• Holmes J, Meier PS, Booth A, Guo Y & Brennan A (2012) The temporal relationship between per capita alcohol consumption and harm: A systematic review of time lag specifications in aggregate time series analyses. Drug and Alcohol Dependence, 123(1-3), 7-14. View this article in WRRO
• Tosh J, Brennan A, Wailoo A & Bansback N (2011) The Sheffield rheumatoid arthritis health economic model.. Rheumatology (Oxford), 50 Suppl 4, iv26-iv31.
• Meier P & Brennan A (2011) O4-6.4 The development of models to underpin public health guidance. Journal of Epidemiology & Community Health, 65(Suppl 1), A47-A47.
• Kharroubi SA, Brennan A & Strong M (2011) Estimating expected value of sample information for incomplete data models using Bayesian approximation.. Med Decis Making, 31(6), 839-852.
• Nagy B, Brennan A, Brandtmüller A, Thomas SK, Sullivan SD & Akehurst R (2011) Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models.. Int J Geriatr Psychiatry, 26(5), 483-494.
• Gillett M, Dixon S, Dallosso HM, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC & Davies MJ (2010) Self management of diabetes Authors' reply. BRIT MED J, 341.
• Karnon J, Brennan A & Akehurst R (2010) Decision Modeling to Inform Decision Making: Seeing the Wood for the Trees. MED DECIS MAKING, 30(3), E20-E22.
• Oakley JE, Brennan A, Tappenden P & Chilcott J (2010) Simulation sample sizes for Monte Carlo partial EVPI calculations.. J Health Econ, 29(3), 468-477. View this article in WRRO
• Karnon J, Holmes MW, Williams R, Bakhai A & Brennan A (2010) A cost-utility analysis of clopidogrel in patients with ST elevation acute coronary syndromes in the UK. INT J CARDIOL, 140(3), 315-322.
• Purshouse RC, Meier PS, Brennan A, Taylor KB & Rafia R (2010) Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model.. Lancet, 375(9723), 1355-1364.
• Meier PS, Purshouse R & Brennan A (2010) Policy options for alcohol price regulation: response to the commentaries.. Addiction, 105(3), 400-401.
• Meier PS, Purshouse R & Brennan A (2010) Policy options for alcohol price regulation: the importance of modelling population heterogeneity.. Addiction, 105(3), 383-393. View this article in WRRO
• Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC & Davies MJ (2010) Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis.. BMJ, 341, c4093.
• Stevenson MD, Oakley JE, Lloyd Jones M, Brennan A, Compston JE, McCloskey EV & Selby PL (2009) The cost-effectiveness of an RCT to establish whether 5 or 10 years of bisphosphonate treatment is the better duration for women with a prior fracture.. Med Decis Making, 29(6), 678-689. View this article in WRRO
• Brennan A, Nagy B, Brandtmüller A, Thomas SK, Gallagher M, Sullivan SD & Akehurst R (2009) The cost-utility of the rivastigmine transdermal patch in the management of patients with moderate Alzheimer's disease in the US. Aktuelle Neurologie, 36(S 02).
• Nagy B, Brennan A, Brandtmüller A, Thomas SK, Gallagher M, Sullivan SD & Akehurst R (2009) Introducing a methodology to use activities of daily living outcomes in the assessment of the cost-effectiveness of AD treatments: a case study using rivastigmine patch. Aktuelle Neurologie, 36(S 02).
• Nixon RM, O'Hagan A, Oakley J, Madan J, Stevens JW, Bansback N & Brennan A (2009) The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulation. PHARM STAT, 8(4), 371-389. View this article in WRRO
• Tappenden P, Chilcott J, Brennan A & Pilgrim H (2009) Systematic review of economic evidence for the detection, diagnosis, treatment, and follow-up of colorectal cancer in the United Kingdom.. Int J Technol Assess Health Care, 25(4), 470-478.
• Nixon RM, Bansback N, Stevens JW, Brennan A & Madan J (2009) Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritis. PHARM STAT, 8(2), 150-162.
• Nagy B, Brennan A, Brandtmuller A, Thomas S, Gallagher M, Sullivan SD & Akehurst R (2008) P2-284: Introducing a methodology to use activities of daily living outcomes in the assessment of the cost-effectiveness of Alzheimer's disease treatments: A case study using rivastigmine patch. Alzheimer's & Dementia, 4, T455-T455.
• Bansback N, Brennan A, Symmons D, Nixon R, Madan J, Harrison M & Watson K (2008) Comment on: Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry: reply. RHEUMATOLOGY, 47(7), 1107-1107.
• Hadwin R, Eggington S, Brennan A, Walker P, Patnick J & Pilgrim H (2008) Modelling the cost-effectiveness and capacity impact of changes to colposcopy referral guidelines for women with mild dyskaryosis in the UK Cervical Screening Programme. BJOG-INT J OBSTET GY, 115(6), 749-757.
• Wailoo AJ, Bansback N, Brennan A, Michaud K, Nixon RM & Wolfe F (2008) Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis.. Arthritis Rheum, 58(4), 939-946.
• Wailoo AJ, Sutton AJ, Cooper NJ, Turner DA, Abrams KR, Brennan A & Nicholson KG (2008) Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza.. Value Health, 11(2), 160-171.
• Brennan A & Kharroubi SA (2007) Expected value of sample information for Weibull survival data.. Health Econ, 16(11), 1205-1225.
• Brennan A, Bansback N, Nixon R, Madan J, Harrison M, Watson K & Symmons D (2007) Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.. Rheumatology (Oxford), 46(8), 1345-1354. View this article in WRRO
• Nixon R, Bansback N & Brennan A (2007) The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons. RHEUMATOLOGY, 46(7), 1140-1147.
• Brennan A, Kharroubi S, O'hagan A & Chilcott J (2007) Calculating partial expected value of perfect information via Monte Carlo sampling algorithms.. Med Decis Making, 27(4), 448-470.
• Karnon J, Brennan A & Akehurst R (2007) A critique and impact analysis of decision modeling assumptions.. Med Decis Making, 27(4), 491-499.
• Ara R & Brennan A (2007) The cost-effectiveness of sibutramine in non-diabetic obese patients: evidence from four Western countries.. Obes Rev, 8(4), 363-371.
• Palmer AJ, Roze S, Valentine WJ, McEwan P, Gillett M, Holmes M, Clarke P, Stevens R, Gray AM, Coleman R , Sorensen S et al (2007) Computer modeling of diabetes and its complications - A report on the Fourth Mount Hood Challenge Meeting. DIABETES CARE, 30(6), 1638-1646.
• Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R & John A (2007) Screening for type 2 diabetes: literature review and economic modelling. HEALTH TECHNOL ASSES, 11(17), 1-+.
• Nixon RM, Bansback N & Brennan A (2007) Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. STAT MED, 26(6), 1237-1254.
• Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R & John A (2007) Screening for type 2 diabetes: Literature review and economic modelling. Health Technology Assessment, 11(17). View this article in WRRO
• Brennan A & Kharroubi SA (2007) Efficient computation of partial expected value of sample information using Bayesian approximation.. J Health Econ, 26(1), 122-148.
• Brennan A, Akehurst R, Davis S, Sakai H & Abbott V (2007) The cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in patients with end-stage renal disease.. Value Health, 10(1), 32-41.
• Brennan A, Ara R, Sterz R, Matiba B & Bergemann R (2006) Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany.. Eur J Health Econ, 7(4), 276-284.
• Brennan A, Chick SE & Davies R (2006) A taxonomy of model structures for economic evaluation of health technologies.. Health Econ, 15(12), 1295-1310.
• Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G , Gough M et al (2006) Accurate, practical and cost-effective assessment of carotid stenosis in the UK. HEALTH TECHNOL ASSES, 10(30), 1-+.
• Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P, Reynolds A & Emery P (2006) Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.. Rheumatology (Oxford), 45(8), 1029-1038.
• Karnon J, Bakhai A, Brennan A, Pandor A, Flather M, Warren E, Gray D & Akehurst R (2006) A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.. Int J Cardiol, 109(3), 307-316.
• Bansback N, Young A, Brennan A & Dixey J (2006) A prognostic model for functional outcome in early rheumatoid arthritis. Journal of Rheumatology, 33(8), 1503-1510.
• Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G , Gough M et al (2006) Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technology Assessment, 10(30). View this article in WRRO
• Brennan A, Sampson F & Deverill M (2005) Can we use routine data to evaluate organizational change? Lessons from the evaluation of business process re-engineering in a UK teaching hospital.. Health Serv Manage Res, 18(4), 265-276.
• Bansback N, Brennan A & Anis AH (2005) A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritis.. Expert Rev Pharmacoecon Outcomes Res, 5(5), 519-529.
• Bansback NJ, Brennan A & Ghatnekar O (2005) Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden.. Ann Rheum Dis, 64(7), 995-1002.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) The Authors' Reply. PharmacoEconomics, 23(8), 853-853.
• Nuijten M, O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M , Spiegelhalter D et al (2005) Incorporation of uncertainty in health economic modelling studies. PharmacoEconomics, 23(8), 851-853.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) Incorporation of uncertainty in health economic modelling studies - The authors' reply. PHARMACOECONOMICS, 23(8), 853-853.
• Bansback NJ, Young A & Brennan A (2005) The NICE reappraisal of biologics in 2005: what rheumatologists need to know. RHEUMATOLOGY, 44(1), 3-4.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) Incorporation of uncertainty in health economic modelling studies.. Pharmacoeconomics, 23(6), 529-536.
• Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, Sculpher M & Tsuchyia A (2005) Should patients have a greater role in valuing health states?. Appl Health Econ Health Policy, 4(4), 201-208.
• Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH & Marra CA (2005) An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.. Drugs, 65(4), 473-496.
• Karnon J, Brennan A, Pandor A, Fowkes G, Lee A, Gray D, Coshall C, Nicholls C & Akehurst R (2005) Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK.. Curr Med Res Opin, 21(1), 101-112.
• Brennan A & Bansback N (2004) Re: Wolfe et al. Do rhematology cost-effectiveness analyses make sense?. RHEUMATOLOGY, 43(5), 677-678.
• Bansback N, Brennan A, Sengupta N & Pang F (2004) THE COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRA (TM)) IN PATIENTS WITH RHEUMATOID ARTHRITIS: A UK ANALYSIS. RHEUMATOLOGY, 43, 77-77.
• Bansback N, Brennan A, Young A, Sollymossy C, Dixey J & Dart H (2004) WHICH PATIENTS WITH EARLY RA DEVELOP FAST PROGRESSIVE DISEASE? PROGNOSTIC FACTORS FOR SEVERE FUNCTIONAL LOSS FROM AN INCEPTION COHORT WITH 9 YEAR FOLLOW UP. RHEUMATOLOGY, 43, 137-137.
• Brennan A, Bansback N, Reynolds A & Conway P (2004) Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.. Rheumatology (Oxford), 43(1), 62-72.
• Warren E, Brennan A & Akehurst R (2004) Cost-effectiveness of sibutramine in the treatment of obesity.. Med Decis Making, 24(1), 9-19.
• Dixon S, Coleman P, Nicholl J, Brennan A & Touch S (2003) Evaluation of the impact of a technology appraisal process in England: the South and West Development and Evaluation Committee.. J Health Serv Res Policy, 8(1), 18-24.
• Karnon J, Brennan A & Chilcott J (2003) Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials".. Eur J Health Econ, 4(3), 239-240.
• Dixon S, Coleman P, Nicholl J, Brennan A & Touch S (2003) Evaluation of the Impact of a Technology Appraisal Process in England: The South and West Development and Evaluation Committee. Journal of Health Services Research & Policy, 8(1), 18-24.
• Chilcott J, Brennan A, Booth A, Karnon J & Tappenden P (2003) The role of modelling in prioritising and planning clinical trials.. Health technology assessment (Winchester, England), 7(23). View this article in WRRO
• Brennan A, Bansback N, Conway P & Reynolds A (2002) MODELLING THE COST-EFFECTIVENESS OF ETANERCEPT IN ADULTS WITH RHEUMATOID ARTHRITIS IN THE UK. RHEUMATOLOGY, 41, 91-91.
• Stevenson M, Beard S, Finn A & Brennan A (2002) Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule.. Vaccine, 20(13-14), 1778-1786.
• Cornell SJ, Chilcott JB & Brennan A (2001) Is it feasible to plan secondary care services for coronary heart disease rationally? A quantified modelling approach for a UK Health Authority.. J Epidemiol Community Health, 55(7), 521-527.
• Stevenson MD, Oakley PA, Beard SM, Brennan A & Cook AL (2001) Triaging patients with serious head injury: results of a simulation evaluating strategies to bypass hospitals without neurosurgical facilities.. Injury, 32(4), 267-274.
• Brennan A & Akehurst R (2000) Modelling in health economic evaluation. What is its place? What is its value?. Pharmacoeconomics, 17(5), 445-459.
• Opazo Breton M, Henney M, Kersbergen I, Brennan A & Holmes J () Expanding our understanding of long‐term trends in alcohol abstention and consumption in England (2001–19) using two age–period–cohort approaches. Addiction.
• Davies MJ, Bodicoat DH, Brennan A, Dixon S, Eborall H, Glab A, Gray LJ, Hadjiconstantinou M, Huddlestone L, Hudson N , Keetharuth A et al () Uptake of self-management education programmes for people with type 2 diabetes in primary care through the embedding package: a cluster randomised control trial and ethnographic study. BMC Primary Care, 25(1).
• Buckell J, Mitchell C, Fryer K, Newbert C, Brennan A, Joyce J, Aveyard P, Jebb S, Guess N & Morris E () Identifying preferred features of weight loss programmes for adults with, or at risk of, type 2 diabetes: a discrete choice experiment with 3,960 adults in the UK. Diabetes Care. View this article in WRRO
• Valiente R, Tunstall H, Kong AY, Wilson LB, Gillespie D, Angus C, Brennan A, Shortt NK & Pearce J () Geographical differences in the financial impacts of different forms of tobacco licence fees on small retailers in Scotland. Tobacco Control.
• Heathcote L, Pollard D, Brennan A, Davies M, Eborall H, Edwardson C, Gillett M, Gray L, Griffin S, Hardeman W , Henson J et al () A cost-effectiveness analysis of two interventions to promote physical activity in a multi-ethnic population at high risk of diabetes: an economic evaluation of the 48 month PROPELS Randomised Controlled Trial. BMJ Open Diabetes Research and Care. View this article in WRRO
• Hatchard J, Buykx P, Brennan A & Gillespie D () Options for modifying UK alcohol and tobacco tax: A rapid scoping review of the evidence over the period 1997–2018. NIHR Open Research, 3, 26-26.
• Hatchard J, Buykx P, Brennan A & Gillespie D () Options for modifying UK alcohol and tobacco tax: A rapid scoping review of the evidence over the period 1997–2018. NIHR Open Research, 3, 26-26.
• Søholm U, Zaremba N, Broadley M, Axelsen JL, Divilly P, Martine-Edith G, Amiel SA, Mader JK, Pedersen-Bjergaard U, McCrimmon RJ , Renard E et al () Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study. JMIR Diabetes, 8, e42100-e42100.
• Hatchard J, Buykx P, Brennan A & Gillespie D () Options for modifying UK alcohol and tobacco tax: A rapid scoping review of the evidence over the period 1997–2018 [version 1; peer review: awaiting peer review]. NIHR Open Research, 3.
• Valiente R, Tunstall H, Kong A, Wilson L, Gillespie D, Angus C, Brennan A, Shortt N & Pearce J () Simulating the impact of a fee scheme to regulate tobacco sales on retailers profits: a case study from Scotland. Tobacco Prevention & Cessation, 9(Supplement).
• Buckley C, Brennan A, Kerr W, Probst C, Puka K, Purshouse R & Rehm J () Improved estimates for individual and population-level alcohol use in the United States, 1984-2020. International Journal of Alcohol and Drug Research.
• Breeze P, Gray LA, Thomas C, Bates SE & Brennan A () Estimating the impact of changes in weight and BMI on EQ-5D-3L: a longitudinal analysis of a behavioural group-based weight loss intervention. Quality of Life Research.
• Wyld L, Reed MWR, Collins K, Ward S, Holmes G, Morgan J, Bradburn M, Walters S, Burton M, Lifford K , Edwards A et al () Improving outcomes for women aged 70 years or above with early breast cancer: research programme including a cluster RCT. Programme Grants for Applied Research, 10(6), 1-114.
• Tew M, Willis M, Asseburg C, Bennett H, Brennan A, Feenstra T, Gahn J, Gray A, Heathcote L, Herman WH , Isaman D et al () Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge. Medical Decision Making, 0272989X2110654-0272989X2110654.
• Meier PS, Holmes J, Brennan A & Angus C () Alcohol policy and gender: a modelling study estimating gender‐specific effects of alcohol pricing policies. Addiction.
• Wilson LB, Pryce R, Hiscock R, Angus C, Brennan A & Gillespie D () Quantile regression of tobacco tax pass-through in the UK 2013–2019. How have manufacturers passed through tax changes for different tobacco products?. Tobacco Control.
• Holmes J, Beard E, Brown J, Brennan A, Meier PS, Michie S, Stevely AK, Webster L & Buykx PF () Effects on alcohol consumption of announcing and implementing revised UK low-risk drinking guidelines: findings from an interrupted time series analysis. Journal of Epidemiology and Community Health.
• Schneider PP, Smith RA, Bullas AM, Bayley T, Haake SSJ, Brennan A & Goyder E () Where should new parkrun events be located? Modelling the potential impact of 200 new events on socio-economic inequalities in access and participation.. View this article in WRRO
• Moyo D, Ally AK, Brennan A, Norman P, Purshouse RC & Strong M () Agile Development of an Attitude-Behaviour Driven Simulation of Alcohol Consumption Dynamics. Journal of Artificial Societies and Social Simulation, 18(3). View this article in WRRO
• Heller S, Lawton J, Amiel S, Cooke D, Mansell P, Brennan A, Elliott J, Boote J, Emery C, Baird W , Basarir H et al () Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes. Programme Grants for Applied Research, 2(5), 1-188. View this article in WRRO
• Brennan A, Buckley C, Vu TM, Probst C, Nielsen A, Bai H, Broomhead T, Greenfield T, Kerr W, Meier PS , Rehm J et al () Introducing CASCADEPOP: an open-source sociodemographic simulation platform for US health policy appraisal. International Journal of Microsimulation, 13(2), 21-60.
• Bates S, Norman P, Breeze P, Brennan A & Ahern A () Mechanisms of action in a behavioural weight-management programme: Latent growth curve analysis. Annals of Behavioral Medicine. View this article in WRRO
• Thomas C, Brennan A, Squires H, Brenner G, Bagguley D, Woods H, Gillett M, Leaviss J, Clowes M, Heathcote L , Cooper K et al () What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation. BMJ Open. View this article in WRRO
• Horton M, Perman-Howe PR, Angus C, Bishop J, Bogdanovica I, Brennan A, Britton J, Brose LS, Brown J, Collin J , Dockrell M et al () The SPECTRUM Consortium: a new UK Prevention Research Partnership consortium focussed on the commercial determinants of health, the prevention of non-communicable diseases, and the reduction of health inequalities. Wellcome Open Research, 6, 6-6.
• Gillett M, Brennan A, Watson P, Khunti K, Davies M, Mostafa S & Gray LJ () The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study. Health Technology Assessment, 19(33), 1-80.
• Wilson LB, Angus C, Pryce R, Holmes J, Brennan A & Gillespie D () Do dual purchasers behave differently? An analysis of purchasing data for households that buy both alcohol and tobacco in the United Kingdom. Addiction.
• Breeze P, Thomas C, Thokala P, LaFortune L, Brayne C & Brennan A () The impact of including costs and outcomes of dementia in a health economic model to evaluate lifestyle interventions to prevent diabetes and cardiovascular disease. Medical Decision Making.
• Moore S, Young T, Irving A, Goodacre S, Brennan A & Amos Y () Controlled observational study and economic evaluation of the effect of city-centre night-time alcohol intoxication management services on the emergency care system compared with usual care. Emergency Medicine Journal.
• Gillespie D, Hatchard J, Squires H, Gilmore A & Brennan A () Conceptualising changes to tobacco and alcohol policy as affecting a single interlinked system. BMC Public Health.
• Coates E, Amiel S, Baird W, Benaissa M, Brennan A, Campbell M, Chadwick P, Chater T, Choudhary P, Cooke D , Cooper C et al () A protocol for a cluster randomised controlled trial of the DAFNEplus (Dose Adjustment for Normal Eating) intervention compared with 5x1 DAFNE: A lifelong approach to promote effective self-management in adults with type 1 diabetes. BMJ Open.
• Wilson LB, Pryce R, Angus C, Hiscock R, Brennan A & Gillespie D () The effect of alcohol tax changes on retail prices: how do on-trade alcohol retailers pass through tax changes to consumers?. The European Journal of Health Economics.
• Purshouse RC, Buckley C, Brennan A & Holmes J () Commentary on Robinson et al . (2021): England needs minimum pricing to tackles alcohol's hidden harms ‐ Scotland's experience shows minimum unit pricing (MUP) on off‐trade alcohol sales is effective. Addiction.
• Opazo Breton M, Gillespie D, Pryce R, Bogdanovica I, Angus C, Hernandez Alava M, Brennan A & Britton J () Understanding long‐term trends in smoking in England, 1972‐2019: an age‐period‐cohort approach. Addiction.

Chapters

• Grimm S, Brennan A & Heath A (2024) Value of Information and Implementation, Value of Information for Healthcare Decision-Making (pp. 251-263).
• Grimm S, Brennan A & Heath A (2023) Value of Information and Implementation, Value of Information for Healthcare Decision-Making (pp. 251-264). Chapman and Hall/CRC
• Payne N, Akehurst R, Beard S, Brennan A, Calvert N, Chilcott J, Mccabe C, Paisley S & Ward S (2017) Supporting purchasing in acute specialties in the trent region, Controlling Costs: Strategic Issues in Health Care Management (pp. 118-130).
• Heath A, Kunst N & Jackson C () Value of Information for Healthcare Decision-Making Chapman and Hall/CRC

Conference proceedings papers

• Hoehn A, Lomax N, Rice H, Angus C, Brennan A, Brown D, Comrie E, Elsenbroich C, Hughes C & Katikireddi SV (2023) OP36 Quality-adjusted life expectancy (QALE) and its association with economic inclusion: a study of local authorities in England, Scotland, and Wales. SSM Annual Scientific Meeting
• Mensah J, Thomas C, Akparibo R & Brennan A (2023) PUBLIC HEALTH ECONOMIC MODELLING IN EVALUATIONS OF SALT AND ALCOHOL POLICIES: A SCOPING REVIEW. VALUE IN HEALTH, Vol. 26(12) (pp S544-S544)
• Mueller J, Breeze P, Griffin S, Brennan A, Hill A, Morris S, Hughes CA, Woolston J, Lachassseigne E, Stubbings M , Sharp S et al (2023) Diabetes Education and Behavioral Weight Management for Type 2 Diabetes: A Randomized Controlled Trial. OBESITY, Vol. 31 (pp 47-48)
• Bryning S, Jones GF, Pollit V & Brennan A (2022) WHEN IS A SIMPLE MODEL GOOD ENOUGH? TOWARDS GREATER USE OF FORMAL METHODS FOR EVALUATING STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS ANALYSIS. VALUE IN HEALTH, Vol. 25(7) (pp S350-S351)
• Holding E, Foster A, Lumley E, Brennan A, Gillett M & Goyder E (2021) Facilitating hospital discharge through housing support : a mixed-methods evaluation of a housing association support service in two UK hospitals. The Lancet, Vol. 398(Supplement 2) (pp S53-S53). Virtual conference, 25 November 2021 - 25 November 2021. View this article in WRRO
• Bates S, Breeze P, Norman P & Brennan A (2021) Exploring the cost effectiveness of behavioural weight-management interventions based on the expected impact on mechanisms of action : a pre-trial health economic modelling study. The Lancet, Vol. 398(Supplement 2) (pp 23-23). Virtual conference, 26 November 2021 - 26 November 2021. View this article in WRRO
• Breeze P, Sworn K, Abraham S, McGrane E, Cantrell A & Brennan A (2021) Estimating the health impact of individual's dietary change across multiple physiological outcomes: a conceptual and simulation model. The Lancet, Vol. 398 (pp S27-S27)
• Clarke AE, St-Pierre Y, Paly V, Bruce IN, Malmberg C, Briggs A, Zhang Y, Choi J & Brennan A (2021) POS0734 EXTRAPOLATION OF LONG-TERM OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS: REPLICATING A HOPKINS LUPUS COHORT ANALYSIS WITH THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC) INCEPTION COHORT. Annals of the Rheumatic Diseases, Vol. 80(Suppl 1) (pp 617.2-618)
• (2020) 41st Annual Meeting of the Society for Medical Decision Making Portland, Oregon, October 20–23, 2019. Medical Decision Making, Vol. 40(1) (pp E1-E379)
• Kunst NR, Wilson ECF, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Glynn D, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2020) PRACTICAL CONSIDERATIONS FOR THE EFFICIENT COMPUTATION OF THE EXPECTED VALUE OF SAMPLE INFORMATION TO PRIORITIZE RESEARCH IN HEALTH CARE. MEDICAL DECISION MAKING, Vol. 40(1) (pp E63-E64)
• Flight L, Julious S, Brennan A & Todd S (2020) METHODS FOR CHOOSING THE BEST DESIGN OF A CLINICAL TRIAL: IMPLEMENTING EXPECTED VALUE OF SAMPLE INFORMATION AND ADJUSTING FOR BIAS INDUCED BY A GROUP SEQUENTIAL DESIGN. MEDICAL DECISION MAKING, Vol. 40(1) (pp E188-E189)
• Holmes J, Beard E, Brennan A, Brown J, Gillespie D, Meier PS, Michie S, Stevely AK, Webster L & Buykx P (2019) Effects on alcohol consumption of announcing revised UK low-risk drinking guidelines : findings from a monthly cross-sectional survey. The Lancet, Vol. 394 (pp S54-S54). London, UK, 29 November 2019 - 29 November 2019. View this article in WRRO
• Pollard D, Brennan A, Coates L & Heller S (2019) PDB65 PRETRIAL MODELLING METHODS TO JUSTIFY AND INFORM THE DESIGN OF LARGE RCTS - EXPECTED VALUE OF SAMPLE INFORMATION FOR THE DAFNEPLUS DIABETES EDUCATION CLUSTER RCT. Value in Health, Vol. 22 (pp S584-S584)
• Brennan A & Pollard D (2019) PDB28 A HEALTH ECONOMIC AND DECISION MODELLING ANALYSIS PLAN FOR AN INTEGRATED DATABASE OF OVER 100 CLINICAL TRIALS MEASURING HYPOGLYCAEMIC ATTACKS FOR PEOPLE WITH DIABETES: A HEDMAP FOR HYPORESOLVE. Value in Health, Vol. 22 (pp S577-S577)
• Schneider PP, Smith R, Bullas A, Haake S, Brennan A & Goyder E (2019) Who has access and who participates in parkrun? - implications for selecting future event locations. European Journal of Public Health, Vol. 29(Supplement_4)
• Hatchard J, Buykx P, Brennan A & Gillespie D (2019) Mapping alcohol and tobacco tax interventions for health in the UK: a qualitative framework analysis. The Lancet, Vol. 394 (pp S51-S51)
• de Vocht F, McQuire C, Brennan A, Egan M, Angus C, Kaner E, Beard E, Brown J, Cummins S, De Angelis D , Carter N et al (2019) Evaluating the impact of individual alcohol licensing decisions on local health and crime: a natural experiment with synthetic controls. The Lancet, Vol. 394 (pp S35-S35)
• O'Cathain A, Croot E, Duncan E, Rousseau N, Sworn K, Turner K, Yardley L & Hoddinott P (2019) Why is the early intervention development phase for complex health care interventions important? An overview of new guidance. Trials, Vol. 20(Supplement 1) (pp 99-99). Brighton, UK, 6 October 2019 - 9 October 2019. View this article in WRRO
• Flight L, Hind D, Julious S, Brennan A & Todd S (2019) Considerations concerning the use of health economics in the design and analysis of adaptive clinical trials - a qualitative study. Trials, Vol. 20(Supplement 1) (pp 109-109). Brighton, UK, 6 October 2019 - 9 October 2019. View this article in WRRO
• Vu TM, Probst C, Epstein JM, Brennan A, Strong M & Purshouse RC (2019) Toward inverse generative social science using multi-objective genetic programming. Proceedings of the Genetic and Evolutionary Computation Conference
• Purshouse RC, Vu T, Bai H, Buckley CM, Nielsen AE, Probst C & Brennan A (2019) ALCOHOL POLICY MODELING USING THEORY - A NEW COMPUTATIONAL PLATFORM FOR DEVELOPING MECHANISM-BASED EXPLANATORY MODELS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 43 (pp 142A-142A)
• Nielsen AE, Brennan A, Kerr W & Purshouse R (2019) SYNTHESIZING THE RATIONAL ADDICTION AND MYOPIC CHOICE ECONOMIC MODELS TO EXPLAIN POPULATION ALCOHOL USE AND UNDERSTAND PRICING POLICIES: AN AGENT-BASED SIMULATION. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 43 (pp 141A-141A)
• Paly V, Brennan A, Mukherjee J, Alemao E, Napoli A, Sidhu M, Perdrizet J, Clarke AE, Bruce I & Briggs A (2019) PSY1 CONCEPTUALIZING A FRAMEWORK FOR MODELING SYSTEMIC LUPUS ERYTHEMATOSUS. Value in Health, Vol. 22 (pp S374-S374)
• Pollard D, Brennan A, Coates L & Heller S (2019) PRETRIAL MODELLING METHODS TO JUSTIFY AND INFORM THE DESIGN OF LARGE RCTS - EXPECTED VALUE OF SAMPLE INFORMATION FOR THE DAFNEPLUS DIABETES EDUCATION CLUSTER RCT. VALUE IN HEALTH, Vol. 22 (pp S584-S584)
• Brennan A & Pollard D (2019) A HEALTH ECONOMIC AND DECISION MODELLING ANALYSIS PLAN FOR AN INTEGRATED DATABASE OF OVER 100 CLINICAL TRIALS MEASURING HYPOGLYCAEMIC ATTACKS FOR PEOPLE WITH DIABETES: A HEDMAP FOR HYPORESOLVE. VALUE IN HEALTH, Vol. 22 (pp S577-S577)
• Purshouse RC, Nielsen A & Brennan A (2018) A CONCEPTUAL FRAMEWORK FOR MODELING ALCOHOL USE DYNAMICS OVER OPULATION HEALTH TIME HORIZONS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 42 (pp 331A-331A)
• Broomhead T, Purshouse R, Strong M, Brennan A, Kerr W, Greenfield T, Nielsen A & Probst C (2018) PLATFORM FOR CALIBRATED, SYSTEM-BASED MODELS OF ALCOHOL USE DYNAMICS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 42 (pp 331A-331A)
• Porter JK, Di Tanna GL, Lipton RB, Brennan A, Palmer S, Sapra S & Villa G (2018) Modeling the Reduction in the Clinical Burden of Migraine with Erenumab Treatment. Value in Health, Vol. 21 (pp S206-S206)
• Brennan A, Pollard D, Coates L, Strong M & Heller S (2017) Expected Value of Sample Information For Individual Level Simulation Models To Inform Stop/Go Decision Making By Public Research Funders: A Methodology for The Dafneplus Diabetes Education Cluster Rct. Value in Health, Vol. 20(9) (pp A776-A776) View this article in WRRO
• Lipton RB, Porter JK, Shah N, Sapra S, Desai P, Villa G, Brennan A, Palmer S & Jansen J (2017) A comparison of approaches to model migraine day frequency in migraine. CEPHALALGIA, Vol. 37 (pp 102-103)
• Porter JK, Brennan A, Palmer S, Sapra S, Shah N, Desai P, Villa G & Lipton AB (2017) MODELING MIGRAINE DAY FREQUENCY USING THE BETA-BINOMIAL DISTRIBUTION: A CASE STUDY OF ERENUMAB AS MIGRAINE PROPHYLAXIS. VALUE IN HEALTH, Vol. 20(5) (pp A329-A329)
• Porter JK, DiTanna GL, Villa G, Brennan A, Palmer S, Lipton RB, Jansen JP, Shah N, Desai P & Sapra S (2017) PARAMETRIC MODELLING OF MIGRAINE DAY FREQUENCY IN MIGRAINE PREVENTION: A CASE STUDY OF ERENUMAB CLINICAL TRIAL DATA. VALUE IN HEALTH, Vol. 20(9) (pp A733-A733)
• Lipton RB, Brennan A, Palmer S, Jansen JP, Hatswell AJ, Porter JK, Di Tanna GL, Villa G, Shah N & Sapra S (2017) NOVEL BIOLOGICS VERSUS CONVENTIONAL PREVENTIVE THERAPIES IN MIGRAINE: A FRAMEWORK FOR ECONOMIC EVALUATION. VALUE IN HEALTH, Vol. 20(9) (pp A732-A732)
• Upsher RJ, Stahl D, Pollard D, Gillett M, Brennan A, Heller S, Ismail K & Winkley K (2017) A Systematic Review of Psychological Interventions to Improve Glycaemic Control in Type 1 Diabetes. DIABETES, Vol. 66 (pp A214-A214)
• Mooney JD, Holmes J, Gavens L, de Vocht F, Hickman M, Lock K & Brennan A (2017) Investigating local policy drivers for alcohol harm prevention: a comparative case study of two local authorities in England. BMC Public Health, Vol. 17(1) View this article in WRRO
• Thokala P, Brennan A, Lafortune L & Brayne C (2016) A Comprehensive Economic Model for Dementia: Diagnosis, Disease Progression and Service Delivery. Value in Health, Vol. 19(7) (pp A853-A853)
• Porter JK, Brennan A, Palmer S, Sapra S & Cristino J (2016) Parametric Simulation of Headache Day Frequency Using A Negative Binomial Distribution: A Case Study of Erenumab in Episodic Migraine. Value in Health, Vol. 19(7) (pp A361-A361)
• de Vocht F, Heron J, Mooney J, Angus C, Lock K, Egan M, Campbell R, Brennan A & Hickman M (2016) P66 Cross-sectional and longitudinal associations between alcohol licensing policies, outlet density and deprivation and population health and crime in England. Journal of Epidemiology and Community Health, Vol. 70(Suppl 1) (pp A83.1-A83)
• de Vocht F, Heron J, Mooney J, Brennan A, Lock K, Campbell R & Hickman M (2015) Estimating the measurable impact of local alcohol licensing policies on population health in England using ecological longitudinal data. The Lancet, Vol. 386 (pp S33-S33)
• Strong M, Brennan A & Oakley J (2015) How to Calculate Value of Information in Seconds Using ‘Savi’, the Sheffield Accelerated Value of Information Web App. Value in Health, Vol. 18(7) (pp A725-A726) View this article in WRRO
• Graham J, McBride D, Stull D, Halliday A, Alexopoulos ST, Balp M, Griffiths M, Agirrezabal I & Brennan A (2015) Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu). Value in Health, Vol. 18(7) (pp A423-A423)
• Meier PS, Holmes J, Meng Y & Brennan A (2014) Choosing between different alcohol pricing and taxation strategies: a comparative policy appraisal using the Sheffield Alcohol Policy Model. The Lancet, Vol. 384 (pp S51-S51)
• Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, Guo Y, Hill-McManus D & Purshouse RC (2013) Minimum unit pricing for alcohol: policy appraisal modelling of income and socioeconomic group-specific effects on consumption, spending, and health harms. LANCET, Vol. 382 (pp 47-47)
• Thokala P, Baalbaki H & Brennan A (2013) TELEMONITORING AFTER DISCHARGE FROM HOSPITAL WITH HEART FAILURE-COST- EFFECTIVENESS MODELLING OF ALTERNATIVE SERVICE DESIGNS. VALUE IN HEALTH, Vol. 16(7) (pp A530-A530)
• Thokala P, Brennan A & Baalbaki H (2013) Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure.. Value Health, Vol. 16(3) (pp A290). United States
• Watson P & Brennan A (2013) The expected value of sample information from the pharmaceutical perspective under conditions of value based pricing.. Value Health, Vol. 16(3) (pp A29). United States
• Sutherland CS, Gillet M, Brennan A, Duran A & Ansolabehere X (2013) THE CANARD PROJECT (PROJET CANARD) COST-EFFECTIVENESS ANALYSIS OF REAL-WORLD OUTCOMES IN A DIABETIC POPULATION: THE IMPACT OF BASELINE CHARACTERISTICS IN FRANCE. VALUE IN HEALTH, Vol. 16(3) (pp A284-A284)
• Kruger J, Brennan A, Thokala P, Basarir H, Jacques R & Elliott J (2013) The cost-effectiveness of five week vs one week DAFNE structured education in Type 1 diabetes: a preliminary evaluation using the Sheffield Type 1 diabetes policy model. DIABETIC MEDICINE, Vol. 30 (pp 131-131)
• Brennan A, Thokala P, Baalbaki H, Stevens JW, Wang J & Pandor A (2012) TELEMONITORING AFTER DISCHARGE WITH HEART FAILURE - COST-EFFECTIVENESS MODELLING OF ALTERNATIVE SERVICE DESIGNS. VALUE IN HEALTH, Vol. 15(7) (pp A360-A360)
• Thokala P, Kruger J & Brennan A (2012) COST-EFFECTIVENESS MODELLING OF TYPE-1 DIABETES. VALUE IN HEALTH, Vol. 15(4) (pp A181-A182)
• Watson P & Brennan A (2012) Validation of an individual patient level simulation of the natural history of systemic Lupus erythematosus against an alternative longitudinal cohort. 2012 Operational Research Society Simulation Workshop, SW 2012 (pp 19-24)
• Tappenden P, Brennan A, Chilcott J & Squires H (2011) USING WHOLE DISEASE MODELLING TO INFORM ECONOMIC RECOMMENDATIONS FOR THE DETECTION, DIAGNOSIS, TREATMENT AND FOLLOW-UP OF COLORECTAL CANCER. VALUE IN HEALTH, Vol. 14(7) (pp A469-A470)
• Tappenden P, Brennan A, Chilcott J & Squires H (2011) A METHODOLOGICAL FRAMEWORK FOR DEVELOPING MODELS OF WHOLE DISEASE AREAS TO INFORM RESOURCE ALLOCATION DECISIONS. VALUE IN HEALTH, Vol. 14(7) (pp A243-A243)
• Watson P, Brennan A, Birch H, Fang H & Petri M (2011) The Natural History and Predictive Factors of Long Term Outcomes in Systemic Lupus Erythematosus.. ARTHRITIS AND RHEUMATISM, Vol. 63(10) (pp S951-S951)
• Meier P, Brennan A & Purshouse R (2010) MODELLING GENERAL AND TARGETED PRICE POLICY OPTIONS: ESTIMATION OF EFFECTS ON DIFFERENT SUBGROUPS OF THE POPULATION. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(6) (pp 251A-251A)
• Brennan A & Gillett M (2010) MODELLING COST EFFECTIVENESS OF BEHAVIOUR MODIFICATION PROGRAMMES AND EFFECTS ON MEDICATION: CASE STUDY OF EDUCATION PROGRAMMES IN DIABETES. VALUE HEALTH, Vol. 13(3) (pp A59-A59)
• Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K & Davies MJ (2009) Cost effectiveness of the DESMOND structured education programme for patients newly diagnosed with type 2 diabetes. DIABETOLOGIA, Vol. 52 (pp S12-S12)
• Brennan A, Gillett M & Duenas A (2008) ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL. VALUE HEALTH, Vol. 11(6) (pp A501-A501)
• Stevenson MD, Rawdin AC, Karnon JD & Brennan A (2008) Clopidogrel is cost-effective compared with aspirin in United Kingdom patients with a myocardial infarction who subsequently sustain an ischaemic stroke or peripheral arterial disease event. VALUE HEALTH, Vol. 11(3) (pp A194-A195)
• Brennan A, Nagy B, Brandtmuller A, Thomas SK, Sullivan SD & Akehurst R (2007) The cost-utility of exelon patch in the management of patients with moderate Alzheimer's disease in the United Kingdom. VALUE HEALTH, Vol. 10(6) (pp A384-A384)
• Brennan A, Wilson R, Davis S, Brandtmuller A & Akehurst R (2007) Economic evaluation of the use of lanthanum carbonate from an Australian perspective. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 22 (pp 186-186)
• Nixon R, Bansback N & Brennan A (2007) Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. VALUE HEALTH, Vol. 10(3) (pp A121-A121)
• Ara RM, Reynolds AV, Conway P & Brennan A (2006) The cost effectiveness of etanercept in patients with severe as in the UK. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 273-274)
• Brennan A, Bansback NJ, Nixon R, Madan J & Symmons D (2006) The cost effectiveness of anti-TNF antagonists in rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Registry. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 179-179)
• Bansback N, Young A, Dixey J & Brennan A (2005) A simple prognostic index in early rheumatoid arthritis for predicting functional outcome at 5 years follow up. RHEUMATOLOGY, Vol. 44 (pp I97-I97)
• Brennan A, Akehurst R, Davis S & Sakai H (2004) Lanthanum carbonate for the treatment of hyperphosphataemia: Development of a cost effectiveness model. VALUE HEALTH, Vol. 7(6) (pp 805-805)
• Bansback NJ, Brennan A & Sengupta N (2004) The cost effectiveness of adalimumab (HUMIRA (R)) in patients with RA: A Finnish analysis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 513-514)
• Bansback NJ, Young A, Sollymossy C, Dixey J & Brennan A (2004) A prognostic model for progressive disease in early rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 110-110)
• Bansback NJ, Brennan A, Sengupta N & Pang F (2004) The cost effectiveness of adalimumab (HUMIRA((R))) in UK patients with moderate to severe RA. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 512-513)
• Brennan A & Ara R (2004) Cost effectivness of obesity treatment with sibutramine in combination with diet and lifestyle advice in Germany. INTERNATIONAL JOURNAL OF OBESITY, Vol. 28 (pp S152-S152)
• Bansback N, Brennan A & Sengupta N (2004) Cost-effectiveness of adalimumab (Humira (TM)) in the treatment of US patients with rheumatoid arthritis (RA). VALUE HEALTH, Vol. 7(3) (pp 241-241)
• Bansback NJ, Brennan A, Sengupta N & Chang KY (2003) Cost effectiveness of adalimumab (HUMIRA (TM), Abbott) in the treatment of patients with moderate to severe rheumatoid arthritis (RA). ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S215-S215)
• Bansback NJ, Brennan A, Ghatnekar O, Sengupta N, Chang KY & Hansen M (2003) The cost-effectiveness of adalimumab (HUMIRA (TM), Abbott) in patients with rheumatoid arthritis: A Swedish analysis.. ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S611-S611)
• Bansback N, Brennan A, Young A, Solymossy C & Dixey J (2003) Identifing groups of RA patients who are fast Progressors from early clinical and radiological. ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S110-S110)
• Brennan A, Ward S & Hummel S (2002) Costing the impact of the cancer service guidance. Journal of Clinical Excellence, Vol. 4(1 SUPPL.) (pp 209-210)
• Bansback N, Brennan A, Conway P & Reynolds AV (2002) A threshold cost-effectiveness comparison of infliximab and etanercept in adults with rheumatoid arthritis in the UK.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S582-S582)
• Brennan A, Bansback N, Martha K, Peacock M & Huttner K (2002) Methods to analyse the economic benefits of a pharmacogenetic (PGt) test to predict response to biologic therapy in RA, and to prioritise further research.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S92-S92)
• Brennan A, Bansback N, Conway P & Reynolds AV (2001) Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis (RA) in the UK.. ARTHRITIS AND RHEUMATISM, Vol. 44(9) (pp S157-S157)
• Bansback N, Brennan A, Reynolds A, Conway P & Hammond T (2001) In rheumatoid arthritis (RA) utility calculations should be derived from EQ5D rather than SF-36 due to floor effects.. ARTHRITIS AND RHEUMATISM, Vol. 44(9) (pp S311-S311)
• (2000) Decision Analytic Modelling in the Economic Evaluation of Health Technologies. PharmacoEconomics, Vol. 17(5) (pp 443-444)
• Tian D, Squires H, Buckley C, Gillespie D, Tattan-Birch H, Shahab L, West R, Brennan A, Brown J & Purshouse R () Incorporating the COM-B model for behavior change into an agent-based model of smoking behaviors: an object-oriented design. Proceedings of the 2024 Winter Simulation Conference. Orlando, Florida, 15 December 2024 - 15 December 2024. View this article in WRRO
• Basirir H, Brennan A, Jacques R, Pollard D, Stevens K, Freeman J, Wales J & Price K () The cost-effectiveness of the KIds in control of food structured education programme for adolescents with type 1 diabetes. Endocrine Abstracts
• Thokala P, Baalbaki H, Lowrie K, Dixon S & Brennan A () Financial modelling for telemonitoring. International Journal of Integrated Care, Vol. 13(7)
• Kruger J, Brennan A, Thokala P, Cooke D & Heller S () Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions: A Case Study in Type 1 Diabetes. ISPOR 17th Annual International Meeting. Washington DC, June 2012.
• Kruger J, Brennan A, Thokala P, Fitzgerald P & Heller S () Incorporating psychosocial characteristics in cost-effectiveness modelling of Type 1 diabetes
• Vu TM, Davies E, Buckley C, Brennan A & Purshouse R () Using Multi-objective Grammar-based Genetic Programming to Integrate Multiple Social Theories in Agent-based Modeling. Lecture notes in computer science View this article in WRRO

Reports

• Forster M, Flight L, Corbacho B, Keding A, Ronaldson S, Tharmanathan P, Welch C, Brennan A & Chick S (2021) Report for the EcoNomics of Adaptive Clinical Trials (ENACT) project: Application of a Bayesian Value-Based Sequential Model of a Clinical Trial to the CACTUS and HERO Case Studies (with Guidance Material for Clinical Trials Units)
• Hill J, Breeze P, Chrysanthou G, Bell H & Brennan A (2019) Summary report of the Health and Labour Outcomes (HaLO) Tool
• Webster L, Angus C, Brennan A & Gillespie D (2018) Smoking and the risks of adult diseases View this article in WRRO
• Hill J, Sechel C, Mukuria C, Brennan A, Roberts J & Bryan M (2018) A feasibility study for building a health and work model. Report prepared for Public Health England
• Pryce RE, Buykx P, Gray L, Stone T, Drummond C & Brennan A (2017) Estimates of alcohol dependence in England based on APMS 2014, including estimates of children living in a household with an adult with alcohol dependence. Prevalence, trends, and amenability to treatment
• Brennan A, Buykx P, Pryce RE, Jones A, Hill-McManus D, Stone T, Ally A, Gillespie D, Meier P, Alston R , Cairns D et al (2016) An Evidence-Based Model for Estimating Requirements for Specialist Alcohol Treatment Capacity in England The Specialist Treatment for Alcohol Model (STreAM) Version 1.0 View this article in WRRO
• Pryce RE, Angus C, Holmes J, Meier P & Brennan A (2016) Model-based appraisal of the comparative impact of Minimum Unit Pricing and taxation policies in Scotland. An adaptation of the Sheffield Alcohol Policy Model version 3,
• Holmes J, Angus C, Buykx P, Ally A, Stone A, Meier P & Brennan A (2016) Mortality and morbidity risks from alcohol consumption in the UK: Analyses using the Sheffield Alcohol Policy Model (v.2.7) to inform the UK Chief Medical Officers’ review of the UK lower risk drinking guidelines
• Holmes J, Lovatt MJ, Ally A, Brennan A & Meier P (2015) A new approach to measuring drinking cultures in Britain
• Koh SCL, Marchand R, Genovese A & Brennan A (2012) Fuel Poverty: Perspectives from the front line View this article in WRRO
• Webster L, Angus C, Holmes J, Brennan A & Gillespie D () Alcohol attributable fractions for England
• Webster L, Angus C, Brennan A & Gillespie D () Smoking attributable fractions for adult diseases in England

Posters

• Nagy B, Brennan A, Brandtmuller A, Thomas SK, Sullivan SD & Akehurst R (2008) Cost-Utility of the Rivastigmine Transdermal Patch in the Management of Patients with Moderate Alzheimer's Disease in the US.
• Sadler S, Angus C, Gell L, Gillespie D, Holmes J, Brennan A & Meier P Comparing socioeconomic gradients in alcohol-related harm between the four UK countries (PHE Applied Epidemiology Scientific Meeting 18-19 March 2015).
• Thokala P, Dodd P, Dixon S & Brennan A Using real world data to structure and populate Markov models - a case study of telemonitoring for heart failure.
• Brennan A, Thokala P, Baalbaki H, Stevens J, Wang J & Pandor A Telemonitoring after discharge with heart failure - costeffectiveness modelling of alternative service designs (2012).
• Basarir H, Kruger J, Brennan A, Thokala P, Jacques R, Dixon S, Elliott J, Heller S & Mansell P The Cost-Effectiveness of 5-week versus 1-week DAFNE Structured Education in Type 1 Diabetes: A Preliminary Evaluation Using the Sheffield Type 1 Diabetes Policy Model (Diabetes UK Professional Conference 13-15 March 2013).
• Kruger J, Brennan A, Thokala P, Basarir H & Heller S The Cost-Effectiveness of Dose Adjustment For Normal Eating (DAFNE) Structured Education in Type 1 Diabetes: An Update using the Sheffield Type 1 Diabetes Policy Model (Diabetes UK Professional Conference 13-15 March 2013).
• Tosh J, Brennan A & Parry G Health economic modelling of the service of care in Sheffield for patients with long term depression.
• Brennan A & Gillett M Modelling cost effectiveness of behaviour modification programmes and effects on medication: case study of education programmes in diabetes.
• Tappenden P, Brennan A, Chilcott J & Squires H Using Whole Disease Modelling to inform economic recommendations for the detection, diagnosis, treatment and followup of colorectal cancer.

Datasets

• Gillespie D, Hatchard J, Squires H, Gilmore A & Brennan A Archived data for ‘Conceptualising the alcohol-tobacco policy system: A qualitative problem structuring methodology study to inform health economics modelling’.

Other

• Gillespie D, Webster L & Brennan A () Understanding the use of transition probabilities in health economic models of smoking: A review to support development of the Sheffield Tobacco Policy Model.
• Gillespie D, Webster L, Angus C & Brennan A () The Sheffield Tobacco Policy Model technical report.

Preprints

• Kunst NR, Wilson E, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Glynn D, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2019) Computing the Expected Value of Sample Information Efficiently: Expertise and Skills Required for Four Model-Based Methods, arXiv.
• Angus C, Holmes J, Purshouse R, Meier P & Brennan A () Does your measure matter? A comparison of alcohol availability measures in Great Britain, Cold Spring Harbor Laboratory.
• Flight L, Brennan A, Chick SE, Forster M, Julious S & Tharmanathan P () Value-Adaptive Clinical Trial Designs for Efficient Delivery of Research – Actions, Opportunities and Challenges for Publicly Funded Trials. View this article in WRRO
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K () Systematic Review and Meta-Analysis of Randomised Controlled Trials of Psychological Interventions to Improve Glycaemic Control in Children and Adults with Type 1 Diabetes.
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K () Systematic Review and Meta-Analysis of Randomised Controlled Trials of Psychological Interventions to Improve Glycaemic Control in Adults with Type 2 Diabetes.
• Richards R, Jones RA, Whittle F, Hughes CA, Hill AJ, Lawlor ER, Bostock J, Bates S, Breeze PR, Brennan A , Thomas CV et al () Development of a Web-Based, Guided Self-help, Acceptance and Commitment Therapy–Based Intervention for Weight Loss Maintenance: Evidence-, Theory-, and Person-Based Approach (Preprint), JMIR Publications Inc..